Easterly Investment Partners’s Jasper Therapeutics JSPR Stock Holding History

Easterly Investment Partners’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$199K	–	277
2021 Q2	$199K	Hold	2,000	–	–	0.02%	105
2021 Q1	$198K	Hold	2,000	–	–	0.02%	105
2020 Q4	$200K	Hold	2,000	–	–	0.03%	100
2020 Q3	$198K	Hold	2,000	–	–	0.01%	82
2020 Q2	$200K	Buy	+2,000	New	+$196K	0.01%	78

Other funds holding JSPR

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPARFS

Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Easterly Investment Partners's JSPR Position: Q3 2021 in Review

Easterly Investment Partners sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 2,000 shares — an estimated $199K sold.

Easterly Investment Partners first reported a position in JSPR in Q2 2020 and held it in 5 quarters. The position peaked at $200K in Q4 2020. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

Easterly Investment Partners reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
Easterly Investment Partners sold 2,000 Jasper Therapeutics shares in Q3 2021, an estimated $199K.
Easterly Investment Partners first reported a position in Jasper Therapeutics in Q2 2020 and held it in 5 quarters.
Easterly Investment Partners's Jasper Therapeutics position peaked at $200K in Q4 2020.
10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on Easterly Investment Partners's 13F filing for Q3 2021, filed 1 Nov 2021.